This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The order, valued at $2,842.80, is for the supply of ondansetron orally disintegrating tablets (4 mg, 30-count) to support healthcare services for military personnel, veterans, and other government beneficiaries.
Chartwell RX has two significant Indefinite Delivery Vehicles (IDVs) that facilitate its work with federal agencies. The first is a Federal Supply Schedule contract with the Department of Veterans Affairs for VISN 12, valued at up to $225,000 through October 2025. The second is a single-award Indefinite Delivery Contract with the DLA Troop Support Medical, valued at over $7 million, running through March 2030. This order is issued against the latter IDV, allowing Chartwell RX to manufacture and distribute a broad spectrum of medications to military treatment facilities worldwide.
The contract does not have a set-aside designation, and no subcontractors are mentioned. This award is part of Chartwell RX's ongoing work as a prime contractor supplying pharmaceuticals to the federal government, including various oral medications such as antibiotics, antivirals, antiemetics, and antifungals.